JP2023074268A - IL-1α expression inhibitor - Google Patents
IL-1α expression inhibitor Download PDFInfo
- Publication number
- JP2023074268A JP2023074268A JP2021187136A JP2021187136A JP2023074268A JP 2023074268 A JP2023074268 A JP 2023074268A JP 2021187136 A JP2021187136 A JP 2021187136A JP 2021187136 A JP2021187136 A JP 2021187136A JP 2023074268 A JP2023074268 A JP 2023074268A
- Authority
- JP
- Japan
- Prior art keywords
- myonectin
- expression
- extract
- composition
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000014509 gene expression Effects 0.000 title claims abstract description 50
- 239000003112 inhibitor Substances 0.000 title claims abstract description 7
- 101710111526 Erythroferrone Proteins 0.000 claims abstract description 60
- 239000000203 mixture Substances 0.000 claims abstract description 41
- 238000004519 manufacturing process Methods 0.000 claims abstract description 18
- 102100030135 Complement C1q tumor necrosis factor-related protein 5 Human genes 0.000 claims abstract 5
- 235000013305 food Nutrition 0.000 claims description 32
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- 210000003491 skin Anatomy 0.000 claims description 14
- 210000002510 keratinocyte Anatomy 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 102100030767 Erythroferrone Human genes 0.000 description 49
- 239000000284 extract Substances 0.000 description 30
- -1 purified fractions Substances 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 108020004999 messenger RNA Proteins 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 241001512940 Curcuma amada Species 0.000 description 9
- 240000002853 Nelumbo nucifera Species 0.000 description 9
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 9
- 240000004584 Tamarindus indica Species 0.000 description 9
- 235000018453 Curcuma amada Nutrition 0.000 description 8
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 210000000663 muscle cell Anatomy 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 235000013361 beverage Nutrition 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 6
- 239000006096 absorbing agent Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000003098 myoblast Anatomy 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000004278 EU approved seasoning Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 235000000002 Phoenix sylvestris Nutrition 0.000 description 5
- 235000020204 cat's claw extract Nutrition 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 235000011194 food seasoning agent Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 229940002508 ginger extract Drugs 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229960005150 glycerol Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- 210000002027 skeletal muscle Anatomy 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 101000938779 Homo sapiens Erythroferrone Proteins 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 235000004298 Tamarindus indica Nutrition 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 229910002091 carbon monoxide Inorganic materials 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000013611 frozen food Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 239000007640 basal medium Substances 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000002957 persistent organic pollutant Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000209445 Nelumbonaceae Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 241001107098 Rubiaceae Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 241000234299 Zingiberaceae Species 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000011472 cat’s claw Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 235000013322 soy milk Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- JWKSQNWLEIABLH-UHFFFAOYSA-N 1-octan-2-yloxydodecane Chemical compound CCCCCCCCCCCCOC(C)CCCCCC JWKSQNWLEIABLH-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GQQNRZHWHWHOLI-UHFFFAOYSA-N 11-(2-decyltetradecoxymethyl)tricosane Chemical compound CCCCCCCCCCCCC(CCCCCCCCCC)COCC(CCCCCCCCCC)CCCCCCCCCCCC GQQNRZHWHWHOLI-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- QAXOFQZVRNEBFD-UHFFFAOYSA-N 2-hydroxyethyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCCO QAXOFQZVRNEBFD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ZGIGZINMAOQWLX-NCZFFCEISA-N 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\COC(C)=O ZGIGZINMAOQWLX-NCZFFCEISA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 241000522234 Caesalpinia Species 0.000 description 1
- 235000007627 Caesalpinia Nutrition 0.000 description 1
- 235000014161 Caesalpinia gilliesii Nutrition 0.000 description 1
- 244000003240 Caesalpinia gilliesii Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 241000407170 Curcuma Species 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- ZGIGZINMAOQWLX-UHFFFAOYSA-N Farnesyl acetate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOC(C)=O ZGIGZINMAOQWLX-UHFFFAOYSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 240000005856 Lyophyllum decastes Species 0.000 description 1
- 235000013194 Lyophyllum decastes Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- YBHQCJILTOVLHD-YVMONPNESA-N Mirin Chemical compound S1C(N)=NC(=O)\C1=C\C1=CC=C(O)C=C1 YBHQCJILTOVLHD-YVMONPNESA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical compound CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000245165 Rhododendron ponticum Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 241000607122 Uncaria tomentosa Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 241000234314 Zingiber Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- POJOORKDYOPQLS-UHFFFAOYSA-L barium(2+) 5-chloro-2-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonate Chemical compound [Ba+2].C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O.C1=C(Cl)C(C)=CC(N=NC=2C3=CC=CC=C3C=CC=2O)=C1S([O-])(=O)=O POJOORKDYOPQLS-UHFFFAOYSA-L 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000012813 breadcrumbs Nutrition 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 235000012839 cake mixes Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000014613 canned/preserved soup Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- FHRUGNCCGSEPPE-UHFFFAOYSA-L disodium;2-(4,5-dibromo-3,6-dioxido-9h-xanthen-9-yl)benzoate;hydron Chemical compound [H+].[Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1C2=CC=C([O-])C(Br)=C2OC2=C(Br)C([O-])=CC=C21 FHRUGNCCGSEPPE-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229940007703 farnesyl acetate Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 235000014109 instant soup Nutrition 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000016046 other dairy product Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229960003351 prussian blue Drugs 0.000 description 1
- 239000013225 prussian blue Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 150000003698 vitamin B derivatives Chemical class 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Images
Landscapes
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
本発明はマイオネクチン(Myonectin)の新たな用途に関し、具体的にはIL-1α発現抑制剤に関する。 TECHNICAL FIELD The present invention relates to new uses of Myonectin, specifically IL-1α expression inhibitors.
マイオネクチンは、筋肉から分泌されるマイオカイン(Myokine)と呼ばれるサイトカインの一種として発見されたが(非特許文献1)、その生理活性についてはまだ不明なことが多く、種々の研究がなされている。
これまでにマイオカインが皮膚において種々機能し肌状態に関与する遺伝子の発現を変動させることが見出され(特許文献1)、特にマイオネクチンを添加したメラノサイトにおいてメラニン生成量が抑制されることからマイオネクチンを美白用組成物の有効成分とすることが提案されている(特許文献2)。
Myonectin was discovered as a type of cytokine called myokine secreted from muscle (Non-Patent Document 1), but its physiological activity is still largely unknown, and various studies have been conducted.
It has been found that myokines function in various ways in the skin and alter the expression of genes involved in skin conditions (Patent Document 1). It has been proposed to use it as an active ingredient in whitening compositions (Patent Document 2).
本発明は、マイオネクチンの新たな機能を見出し、好適な用途を提供することを課題とする。 An object of the present invention is to discover new functions of myonectin and to provide suitable uses.
本発明者が鋭意研究を行った結果、マイオネクチンがケラチノサイトにおけるIL-1α発現を抑制することに想到し、本発明を完成するに至った。 As a result of intensive studies by the present inventors, the present inventors have conceived that myonectin suppresses the expression of IL-1α in keratinocytes, and have completed the present invention.
すなわち、本発明は以下の通りである。
[1]マイオネクチンを含有する、IL-1α発現抑制剤。
[2]ケラチノサイトにおけるIL-1α発現を抑制する、[1]に記載の剤。
[3]皮膚外用剤に含有される、[1]又は[2]に記載の剤。
[4]飲食品に含有される、[1]又は[2]に記載の剤。
[5]マイオネクチン産生促進剤を含有する、IL-1α発現抑制用組成物。
[6]皮膚外用剤である、[5]に記載の組成物。
[7]飲食品である、[5]に記載の組成物。
That is, the present invention is as follows.
[1] IL-1α expression inhibitor containing myonectin.
[2] The agent of [1], which suppresses IL-1α expression in keratinocytes.
[3] The agent according to [1] or [2], which is contained in an external preparation for skin.
[4] The agent according to [1] or [2], which is contained in food or drink.
[5] A composition for suppressing IL-1α expression, containing a myonectin production promoter.
[6] The composition of [5], which is an external preparation for skin.
[7] The composition according to [5], which is a food or drink.
本発明により、マイオネクチンのIL-1α発現抑制という新たな用途が提供される。また、マイオネクチン産生促進剤をIL-1α発現抑制用組成物に含有させる態様が提供される。本発明の剤及び組成物は、飲食品や皮膚外用剤の態様とすることができ、手軽にまた継続的に生活に取り入れることができる。 INDUSTRIAL APPLICABILITY The present invention provides a new use of myonectin for suppressing IL-1α expression. Also provided is an embodiment in which a myonectin production-enhancing agent is contained in a composition for suppressing IL-1α expression. The agent and composition of the present invention can be in the form of foods, beverages, or external preparations for skin, and can be easily and continuously incorporated into daily life.
本発明の第一の態様は、マイオネクチンを含有するIL-1α発現抑制剤である。
本発明のIL-1α発現抑制剤におけるマイオネクチンの含有量は、剤全量に対して、好ましくは0.01質量%以上、より好ましくは0.1質量%以上、さらに好ましくは1質量%以上である。マイオネクチンはヒトを含む哺乳類において筋肉から分泌され生体内に存在するタンパク質であるが、本発明の剤は前述した含有量においてマイオネクチンを包含する筋肉等と通常は区別される。
A first aspect of the present invention is an IL-1α expression inhibitor containing myonectin.
The content of myonectin in the IL-1α expression inhibitor of the present invention is preferably 0.01% by mass or more, more preferably 0.1% by mass or more, and still more preferably 1% by mass or more, relative to the total amount of the agent. . Myonectin is a protein that is secreted from muscles in mammals including humans and is present in vivo.
マイオネクチンは、任意の方法で入手することができ、例えば、マイオネクチンをコードする遺伝子(CTRP15)のDNAを用いて、周知の遺伝子工学的手法によりタンパク質を生合成し、単離、精製により取得することができる。 Myonectin can be obtained by any method. For example, using the DNA of the gene (CTRP15) encoding myonectin, the protein is biosynthesized by a well-known genetic engineering technique, and obtained by isolation and purification. can be done.
また、生体内においてマイオネクチンの産生を促進させる成分、すなわちマイオネクチン産生促進剤をIL-1α発現抑制のための有効成分とすることもできる。すなわち、本発明本発明の第二の態様は、マイオネクチン産生促進剤を含有するIL-1α発現抑制用組成物である。マイオネクチン産生促進剤は筋細胞においてマイオネクチンの産生を促し、産生したマイオネクチンがケラチノサイトにおけるIL-1αの発現を抑制する。 A component that promotes the production of myonectin in vivo, ie, a myonectin production promoter, can also be used as an active component for suppressing IL-1α expression. That is, the second aspect of the present invention is a composition for suppressing IL-1α expression containing a myonectin production promoter. The myonectin production promoter promotes the production of myonectin in muscle cells, and the produced myonectin suppresses the expression of IL-1α in keratinocytes.
マイオネクチン産生促進剤は、筋細胞においてマイオネクチン遺伝子(FAM132B)の発現を直接的又は間接的に亢進させる成分をいう。ここで筋細胞は筋芽細胞や筋線維を含む。 A myonectin production promoter refers to a component that directly or indirectly enhances the expression of the myonectin gene (FAM132B) in muscle cells. Here, muscle cells include myoblasts and muscle fibers.
マイオネクチン産生促進剤としては、植物抽出物、化合物等特に限定されないが、例えばマンゴージンジャーエキス、ハスの花エキス、キャッツクローエキス、及びインディアンデーツエキス等の植物抽出物が好ましく挙げられる。
マンゴージンジャーエキスは、ショウガ科ウコン属マンゴージンジャー(Curcuma amada)の抽出物である。
ハスの花エキスは、ハス科ハス属ハス(Nelumbo nucifera)の花又は花蕾の抽出物である。
キャッツクローエキスは、アカネ科カギカズラ属キャッツクロー(Uncaria tomentosa
)の抽出物である。
インディアンデーツエキスは、マメ科ジャケツイバラ亜科タマリンド属タマリンド(Tamarindus indica)の抽出物である。
The myonectin production promoter is not particularly limited to plant extracts, compounds and the like, but preferred examples include plant extracts such as mango ginger extract, lotus flower extract, cat's claw extract, and Indian date extract.
The mango ginger extract is an extract of curcuma mango ginger (Curcuma amada) belonging to the Zingiberaceae family.
The lotus flower extract is an extract of the flower or flower bud of Nelumbo nucifera of the Lotus family.
Cat's claw extract is from the genus Uncaria tomentosa of the family Rubiaceae.
) is an extract of
The Indian date extract is an extract of Tamarindus indica, genus Tamarind, leguminosae, Caesalpinia.
本発明において上記抽出物は、抽出物自体のみならず、抽出物の画分、精製した画分、抽出物又は画分、精製物の溶媒除去物の総称を意味するものとする。 In the present invention, the above-mentioned extract means not only the extract itself, but also a general term for fractions of extracts, purified fractions, extracts or fractions, and solvent-removed products of purified products.
また、抽出物としては、植物体から常法により抽出されたものを用いることができる。
抽出物では例えば、植物の全体(全草)を用いるほか、植物体、地上部、根茎部、木幹部、葉部、茎部、花、花蕾、果実等の部位を用いて抽出操作に供される。ただし、ハスの花エキスにおいては、花又は花蕾が抽出操作に供される。
抽出溶媒としては、水、エタノール、イソプロピルアルコール、ブタノールなどのアルコール類、1,3-ブタンジオール、ポリプロピレングリコールなどの多価アルコール類、アセトン、メチルエチルケトンなどのケトン類、ジエチルエーテル、テトラヒドロフランなどのエーテル類等の極性溶媒から選択される一種又は二種以上が好適に用いられる。
Moreover, as an extract, what was extracted from the plant body by the conventional method can be used.
For extracts, for example, in addition to using the whole plant (whole plant), parts such as plant body, ground part, rhizome part, tree trunk, leaf part, stem part, flower, flower bud, fruit, etc. are subjected to extraction operation. be. However, in the lotus flower extract, the flowers or flower buds are subjected to the extraction operation.
Extraction solvents include water, alcohols such as ethanol, isopropyl alcohol and butanol, polyhydric alcohols such as 1,3-butanediol and polypropylene glycol, ketones such as acetone and methyl ethyl ketone, and ethers such as diethyl ether and tetrahydrofuran. One or two or more selected from polar solvents such as are preferably used.
具体的な抽出方法としては、例えば、植物体等の抽出に用いる部位又はその乾燥物1質量部に対して、溶媒を1~30質量部加え、室温であれば数日間、沸点付近の温度であれば数時間浸漬し、室温まで冷却した後、所望により不溶物及び/又は溶媒除去し、カラムクロマトグラフィー等で分画精製する方法が挙げられる。 As a specific extraction method, for example, 1 to 30 parts by mass of a solvent is added to 1 part by mass of the part used for extraction of a plant or the like or its dried product, and at room temperature for several days, at a temperature near the boiling point. If possible, a method of immersing for several hours, cooling to room temperature, optionally removing insoluble matter and/or solvent, and fractionating and purifying by column chromatography or the like can be mentioned.
本発明の組成物におけるマンゴージンジャーエキス、ハスの花エキス、キャッツクローエキス、及び/又はインディアンデーツエキスの総含有量は、組成物全体に対して、固形物換算で0.0001~50質量%が好ましく、0.001~30質量%がより好ましく、0.001~10質量%がさらに好ましい。
含有量を上記範囲とすることで所望の効果を得やすく、また処方設計の自由度を確保できる。
なお、上記含有量は、後述する投与経路や含有させる組成物の態様に合わせて適宜調整することができる。
The total content of mango ginger extract, lotus flower extract, cat's claw extract, and/or Indian date extract in the composition of the present invention is 0.0001 to 50% by mass in terms of solid matter with respect to the entire composition. It is preferably 0.001 to 30% by mass, even more preferably 0.001 to 10% by mass.
By setting the content within the above range, the desired effect can be easily obtained, and the degree of freedom in prescription design can be ensured.
The above content can be appropriately adjusted according to the administration route and composition to be contained, which will be described later.
後述の実施例で示す通り、マイオネクチンが添加されたケラチノサイトでは、IL-1α発現量が抑制される。特に、スクラッチによる損傷などの物理的刺激を加えられたケラチノサイトにおいては通常IL-1αの発現が亢進するところ、かかる発現を抑制することができる。また、何らかの化学的刺激や紫外線刺激を加えられたケラチノサイトにおいても同様の効果が期待される。そのため、本発明の剤はIL-1α発現抑制用途に好適に用いることができる。また、本発明の組成物は、生体内でマイオネクチンの産生を促進しその結果IL-1α発現抑制作用を発揮する。
ここで、発現量の抑制とは、本発明の剤又は組成物を適用しない場合に比べてIL-1αをコードする遺伝子又はIL-1αタンパク質の発現量が小さいことをいう。
As shown in Examples below, IL-1α expression level is suppressed in keratinocytes to which myonectin is added. In particular, IL-1α expression, which is normally enhanced in keratinocytes that have been subjected to physical stimulation such as damage by scratching, can be inhibited. A similar effect is also expected for keratinocytes subjected to some chemical stimulus or ultraviolet stimulus. Therefore, the agent of the present invention can be suitably used for suppressing IL-1α expression. In addition, the composition of the present invention promotes the production of myonectin in vivo and, as a result, exerts an IL-1α expression-suppressing effect.
Here, suppression of the expression level means that the expression level of the IL-1α-encoding gene or IL-1α protein is smaller than when the agent or composition of the present invention is not applied.
本発明の剤及び組成物は、IL-1α量の増加に起因する状態や疾患や、IL-1α量の減少により改善する状態や疾患の、予防、改善及び/又は治療のために好適に用いることができる。 The agents and compositions of the present invention are suitably used for the prevention, amelioration and/or treatment of conditions and diseases caused by increased IL-1α levels and conditions and diseases ameliorated by decreased IL-1α levels. be able to.
本発明の剤及び組成物の投与経路は、経口、経皮、経鼻、静脈注射等、特に限定されないが、経口投与又は経皮投与されることが好ましい。なお、ここで「投与」は「摂取」と置換されてもよい。 The administration route of the agent and composition of the present invention is not particularly limited and may be oral, transdermal, nasal or intravenous injection, but oral or transdermal administration is preferred. In addition, "administration" may be replaced with "ingestion" here.
本発明の剤又は組成物を経口投与で摂取する場合は、飲食品とすることが好ましい。
本発明の剤を飲食品の態様とする場合は、マイオネクチンの含有量を組成物全量に対して総量で、好ましくは0.01~20質量%、より好ましくは0.1~10質量%、さらに好ましくは1~5質量%とすると、所望の効果を得やすく、また処方設計の自由度を確保できる。
本発明のマイオネクチンを含有する飲食品の好ましい摂取量は特に限定されないが、成人が摂取する場合、マイオネクチン量換算で1日当たり0.001~1000mg/kg(体重)とすることが、十分に効果が発揮される観点から好ましく、更に0.01~100mg/kg(体重)、特に0.1~10mg/kg(体重)とすることが好ましい。この1日分の量を一度に又は数回に分けて摂取することができる。また、単回摂取する他に
、連続的に又は断続的に数週間~数か月の間摂取することが好ましい。
When the agent or composition of the present invention is orally administered, it is preferably prepared as food or drink.
When the agent of the present invention is in the form of a food or drink, the total content of myonectin relative to the total amount of the composition is preferably 0.01 to 20% by mass, more preferably 0.1 to 10% by mass, and further When the amount is preferably 1 to 5% by mass, the desired effect can be easily obtained, and the degree of freedom in prescription design can be ensured.
The preferred intake amount of the food and drink containing myonectin of the present invention is not particularly limited, but when ingested by an adult, 0.001 to 1000 mg/kg (body weight) per day in terms of the amount of myonectin is sufficiently effective. It is preferable from the viewpoint of exertion, more preferably 0.01 to 100 mg/kg (body weight), particularly preferably 0.1 to 10 mg/kg (body weight). This daily amount can be taken at once or divided into several times. In addition to single ingestion, continuous or intermittent ingestion for several weeks to several months is preferred.
本発明の組成物を飲食品の態様とする場合は、これに含有させるマイオネクチン産生促進剤の量は、該産生促進剤によって適宜調整すればよい。例えばマイオネクチン産生促進作用を有する植物抽出物の場合は、固形物換算で1~100mg/日を1回又は数回に分けて摂取される量となるように含有させることが好ましい。また、単回摂取する他に、連続的に又は断続的に数週間~数か月の間摂取することが好ましい。 When the composition of the present invention is in the form of a food or drink, the amount of the myonectin production-enhancing agent contained therein may be appropriately adjusted according to the production-enhancing agent. For example, in the case of a plant extract that promotes myonectin production, it is preferable to contain 1 to 100 mg/day in terms of solid matter so that it can be ingested once or in several divided doses. In addition to single ingestion, continuous or intermittent ingestion for several weeks to several months is preferred.
本発明の剤又は組成物を飲食品の態様とする場合、その製造に際しては、飲食品製造において通常使用される成分を任意に配合することができる。
かかる任意成分としては例えば、タンパク質、炭水化物、脂肪、栄養素、調味料及び香味料等を用いることができる。炭水化物としては、単糖類、例えば、ブドウ糖、果糖など;二糖類、例えば、マルトース、スクロース、オリゴ糖など;及び多糖類、例えば、デキストリン、シクロデキストリンなどのような通常の糖及び、キシリトール、ソルビトール、エリトリトールなどの糖アルコールが挙げられる。香味料としては、天然香味料(タウマチン、ステビア抽出物等)及び合成香味料(サッカリン、アスパルテーム等)を使用することができる。その他に、前述の医薬組成物で用いられる添加物であって通常食品にも添加されるものを同様に用いてもよい。
When the agent or composition of the present invention is in the form of a food or drink, ingredients that are commonly used in the production of food or drink can be arbitrarily blended in the production thereof.
Such optional ingredients can include, for example, proteins, carbohydrates, fats, nutrients, seasonings and flavors. Carbohydrates include monosaccharides such as glucose, fructose, etc.; disaccharides such as maltose, sucrose, oligosaccharides, etc.; sugar alcohols such as erythritol; As flavoring agents, natural flavoring agents (thaumatin, stevia extract, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be used. In addition, additives that are used in the pharmaceutical compositions described above and that are usually added to foods may also be used.
飲食品の形態としては、液状、ペースト状、固体、粉末、顆粒等の形態を問わない。また、錠菓、流動食、飼料等も飲食品の態様に含まれる。 The form of food and drink may be liquid, paste, solid, powder, granules, or the like. In addition, tablets, liquid foods, feeds, etc. are also included in the mode of food and drink.
また、他に一般の飲食品に含有させる態様であってもよく、例えば、パン、マカロニ、スパゲッティ、めん類、ケーキミックス、から揚げ粉、パン粉の小麦粉製品;、即席めん、カップめん、レトルト・調理食品、調理缶詰め、電子レンジ食品、即席スープ・シチュー、即席みそ汁・吸い物、スープ缶詰め、フリーズ・ドライ食品等の即席食品;農産缶詰め、果実缶詰め、ジャム・マーマレード類、漬物、煮豆類、農産乾物類、シリアル(穀物加工品)等の農産加工品;水産缶詰め、魚肉ハム・ソーセージ、水産練り製品、水産珍味類、つくだ煮類等の水産加工品;畜産缶詰め・ペースト類、畜肉ハム・ソーセージ等の畜産加工品;加工乳、乳飲料、ヨーグルト類、乳酸菌飲料類、チーズ、アイスクリーム類、調製粉乳類、クリーム、その他の乳製品等の乳・乳製品;バター、マーガリン類、植物油等の油脂類;しょうゆ、みそ、ソース類、トマト加工調味料、みりん類、食酢類等の基礎調味料;調理ミックス、カレーの素類、たれ類、ドレッシング類、めんつゆ類、スパイス類、その他の複合調味料等の複合調味料・食品類;素材冷凍食品、半調理冷凍食品、調理済冷凍食品等の冷凍食品;キャラメル、キャンディー、チューインガム、チョコレート、クッキー、ビスケット、ケーキ、パイ、スナック、クラッカー、和菓子、米菓子、豆菓子、デザート菓子等の菓子類;炭酸飲料、天然果汁、果汁飲料、果汁入り清涼飲料、果肉飲料、果粒入り果実飲料、野菜系飲料、豆乳、豆乳飲料、コーヒー飲料、お茶飲料、粉末飲料、濃縮飲料、スポーツ飲料、栄養飲料、アルコール飲料等の飲料類;これら以外の食品等に、本発明の剤又は組成物を添加してもよい。 In addition, it may be contained in other general food and drink products, such as bread, macaroni, spaghetti, noodles, cake mixes, fried chicken flour, bread crumb flour products; instant noodles, cup noodles, retort and cooked foods , Cooked canned food, Microwave food, Instant soup/stew, Instant miso soup/Soup, Canned soup, Instant food such as freeze-dried food; Agricultural processed products such as cereals (processed grain products); Processed marine products such as canned marine products, fish ham and sausages, fish paste products, marine delicacies, and tsukudani products; Milk and dairy products such as processed milk, milk drinks, yogurts, lactic acid beverages, cheese, ice creams, formulated milk powders, cream, and other dairy products; Oils and fats such as butter, margarine, and vegetable oil; Soy sauce, Basic seasonings such as miso, sauces, processed tomato seasonings, mirin, and vinegar; complex seasonings such as cooking mixes, curry ingredients, sauces, dressings, noodle soups, spices, and other complex seasonings Frozen foods such as frozen foods, semi-cooked frozen foods, and cooked frozen foods; caramels, candies, chewing gums, chocolates, cookies, biscuits, cakes, pies, snacks, crackers, Japanese sweets, rice sweets, bean sweets , Confectionery such as desserts; carbonated drinks, natural fruit juices, fruit juice drinks, soft drinks containing fruit juice, pulp drinks, fruit drinks containing fruit, vegetable drinks, soy milk, soy milk drinks, coffee drinks, tea drinks, powdered drinks, concentrates The agent or composition of the present invention may be added to beverages such as beverages, sports drinks, nutritional drinks, and alcoholic beverages; and foods other than these.
本発明の飲食品の態様としては、通常の食品、飲料、機能性表示食品、特定保健用食品等の保健機能食品、サプリメント等が挙げられ、特に機能性表示食品が好ましい。
本発明の飲食品をIL-1α発現抑制用途とする場合、製品化の際にその有する有用性や機能性に関する表示を付してもよい。
かかる「表示」行為には、需要者に対して前記用途を知らしめるための全ての行為が含まれ、「IL-1αの発現を抑える」といった用途を想起・類推させうるような表現であれば、表示の目的、表示の内容、表示する対象物・媒体等の如何に拘わらず、全て本発明の「表示」行為に該当する。
また、「表示」は、需要者が上記用途を直接的に認識できるような表現により行われる
ことが好ましい。具体的には、飲食品に係る商品又は商品の包装、容器等に前記用途を記載したものを譲渡し、引き渡し、譲渡若しくは引き渡しのために展示し、輸入する行為、商品に関する広告、価格表、カタログ、パンフレット、POP等の販売現場における宣伝材等、若しくは取引書類に上記用途を記載して展示し、若しくは頒布し、又はこれらを内容とする情報に上記用途を記載して電磁気的(インターネット等)方法により提供する行為等が挙げられる。なお、本発明の飲食品が保健機能食品等の行政が定める各種制度に基づいて認可を受けその認可のもとで実施される場合は、該認可に基づく態様で表示することが好ましい。
Embodiments of the food and drink of the present invention include ordinary foods, beverages, foods with function claims, foods with health claims such as foods for specified health uses, supplements, etc. Foods with function claims are particularly preferred.
When the food or drink of the present invention is used for suppressing IL-1α expression, the usefulness and functionality of the food and drink may be indicated at the time of commercialization.
Such "display" acts include all acts for informing consumers of the above uses, and expressions such as "suppressing the expression of IL-1α" that can remind or infer the uses are included. , the purpose of the display, the content of the display, the object or medium to be displayed, etc., all fall under the "display" act of the present invention.
In addition, it is preferable that the "display" be performed in an expression that allows the consumer to directly recognize the use. Specifically, the act of transferring, handing over, displaying for the purpose of transfer or delivery, importing products related to food and beverages or packaging, containers, etc. of products with the above-mentioned use, advertisements related to products, price lists, Exhibiting or distributing the above-mentioned use in advertising materials at sales sites such as catalogs, pamphlets, POPs, etc., or transaction documents, or describing the above-mentioned use in information containing these and electromagnetically (Internet, etc.) ) act of providing by the method. In addition, when the food and drink of the present invention are approved based on various systems such as food with health claims and implemented under the approval, it is preferable to display in a manner based on the approval.
本発明の剤又は組成物を経皮投与する態様としては、化粧料、医薬部外品、及び医薬品等の皮膚外用剤が好ましい。皮膚外用組成物の剤型としては、特に限定されず、例えば、ローション剤型、乳液やクリーム等の乳化剤型、オイル剤型、ジェル剤型、パック剤型等が挙げられる。 As a mode of transdermal administration of the agent or composition of the present invention, skin external preparations such as cosmetics, quasi-drugs, and pharmaceuticals are preferable. The formulation of the composition for external use on skin is not particularly limited, and examples thereof include lotions, emulsifiers such as milky lotions and creams, oil formulations, gel formulations, pack formulations, and the like.
本発明の剤を皮膚外用剤の態様とする場合は、マイオネクチンの含有量を組成物全量に対して総量で、好ましくは0.01~20質量%、より好ましくは0.1~10質量%、さらに好ましくは1~5質量%とすると、所望の効果を得やすく、また処方設計の自由度を確保できる。
本発明の組成物を皮膚外用剤の態様とする場合は、これに含有させるマイオネクチン産生促進剤の量は、該産生促進剤によって適宜調整すればよい。例えばマイオネクチン産生促進作用を有する植物抽出物の場合は、組成物全量に対して総量で、好ましくは0.01~20質量%、より好ましくは0.1~10質量%、さらに好ましくは1~5質量%とすると、所望の効果を得やすく、また処方設計の自由度を確保できる。
When the agent of the present invention is an external skin preparation, the total content of myonectin is preferably 0.01 to 20% by mass, more preferably 0.1 to 10% by mass, based on the total amount of the composition. More preferably, 1 to 5% by mass makes it easier to obtain the desired effect, and ensures freedom in formulation design.
When the composition of the present invention is used as an external preparation for skin, the amount of the myonectin production-enhancing agent contained therein may be appropriately adjusted according to the production-enhancing agent. For example, in the case of a plant extract having a myonectin production promoting effect, the total amount is preferably 0.01 to 20% by mass, more preferably 0.1 to 10% by mass, and still more preferably 1 to 5% by mass relative to the total amount of the composition. % by mass, the desired effect can be easily obtained, and the degree of freedom in prescription design can be ensured.
本発明の剤又は組成物は、皮膚外用剤の態様である場合、マイオネクチン又はマイオネクチン産生剤以外に通常の皮膚外用組成物に配合される成分を、本発明の効果を損なわない限りにおいて任意に含有することができる。
かかる成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ-2-エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ-2-エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ-2-ヘプチルウンデカン酸グリセリン、トリ-2-エチルヘキサン酸グリセリン、トリ-2-エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ-2-エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;
When the agent or composition of the present invention is in the form of an external preparation for skin, it optionally contains components other than myonectin or a myonectin-producing agent, which are usually blended in external compositions for skin, as long as they do not impair the effects of the present invention. can do.
Such ingredients include, for example, macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil, hydrogenated oil. , Japanese wax, hydrogenated castor oil, beeswax, candelilla wax, carnauba wax, ibota wax, lanolin, reduced lanolin, hard lanolin, jojoba wax, oils and waxes; liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, vaseline, microcrystalline Hydrocarbons such as wax; Higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; Cetyl alcohol, stearyl alcohol, isostearyl alcohol, behenyl alcohol, octyldodeca Higher alcohols such as nol, myristyl alcohol, cetostearyl alcohol, etc.; ethylene glycol 2-ethylhexanoate, neopentyl glycol dicaprate, glyceryl di-2-heptylundecanoate, glyceryl tri-2-ethylhexanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, Synthetic ester oils such as tetra-2-ethylhexanoic acid pentane erythritol; chain polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane; octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethyl Cyclic polysiloxanes such as cyclohexanesiloxane; oils such as silicone oils such as modified polysiloxanes such as amino-modified polysiloxanes, polyether-modified polysiloxanes, alkyl-modified polysiloxanes, and fluorine-modified polysiloxanes;
脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸
カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2-ココイル-2-イミダゾリニウムヒドロキサイド-1-カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE-ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE-グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2-オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック(登録商標)型類、POE・POPアルキルエーテル類(POE・POP2-デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3-ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2-ペンタンジオール、2,4-ヘキサンジオール、1,2-ヘキサンジオール、1,2-オクタンジオール等の多価アルコール類;
Anionic surfactants such as fatty acid soaps (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, alkyl sulfate triethanolamine ether; cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride, laurylamine oxide Class; imidazoline amphoteric surfactant (2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactant (alkylbetaine, amidobetaine, sulfobetaine, etc.), acyl Amphoteric surfactants such as methyl taurine; sorbitan fatty acid esters (sorbitan monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (glyceryl monostearate, etc.), propylene glycol fatty acid esters (propylene glycol monostearate, etc.) ), hydrogenated castor oil derivatives, glycerin alkyl ether, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbitol fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin Fatty acid esters (POE-glycerin monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE 2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonyl phenyl ether, etc.), Pluronic (registered trademark) types, POE/POP alkyl ethers (POE/POP 2-decyltetradecyl ether, etc.), tetronics, POE castor oil/hardened castor oil derivatives (POE castor oil, POE hardened Castor oil, etc.), nonionic surfactants such as sucrose fatty acid esters, alkyl glucosides; polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, di Polyhydric alcohols such as glycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol and 1,2-octanediol;
ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていてもよい、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類;表面を処理されていてもよい、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;表面を処理されていてもよい、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパ-ル剤類;レ-キ化されていてもよい赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤;桂皮酸系紫外線吸収剤;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2-(2'-ヒドロキシ-5'-t-オクチルフェニル)ベンゾトリアゾール、4-メトキ
シ-4'-t-ブチルジベンゾイルメタン等の紫外線吸収剤類;
Moisturizing ingredients such as sodium pyrrolidonecarboxylate, lactic acid, sodium lactate; optionally surface-treated mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, sulfuric acid Powders such as barium; Inorganic pigments such as red iron oxide, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine blue, Prussian blue, titanium oxide, and zinc oxide that may be surface-treated; mica titanium, fish phosphorus foil, bismuth oxychloride, etc.; Organic dyes such as No. 5, Red No. 505, Red No. 230, Red No. 223, Orange No. 201, Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, Red No. 204, etc. Organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer; para-aminobenzoic acid UV absorbers; anthranilic acid UV absorbers; salicylic acid UV absorbers; cinnamic acid UV absorbers Agent; Benzophenone UV absorber; Sugar UV absorber; 2-(2'-hydroxy-5'-t-octylphenyl)benzotriazole, 4-methoxy-4'-t-butyldibenzoylmethane, etc. agents;
エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類;α-トコフェロール、β-トコフェロール、γ-トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;メチルパラベン、エチルパラベン、ブチルパラベン、フェノキシエタノール等の抗菌剤(防腐剤);グリチルリチン酸誘導体、グリチルレチン酸誘導体、サリチル酸誘導体、ヒノキチオール、酸化亜鉛、アラントイン等の消炎剤;レチノール、アスコルビン酸、トコフェロール、又はファルネシル酢酸エステル等のシワ改善剤;各種抽出物(例えば、オウバク、オウレン、シコン、シャクヤク、センブリ、バーチ、セージ、ビワ、ニンジン、アロエ、ゼニアオイ、アイリス、ブドウ、ヨクイニン
、ヘチマ、ユリ、サフラン、センキュウ、ショウキュウ、オトギリソウ、オノニス、ニンニク、トウガラシ、チンピ、トウキ、海藻等);ローヤルゼリー、感光素、コレステロール誘導体等の賦活剤;ノニル酸ワレニルアミド、カプサイシン、ジンゲロン、タンニン酸等の血行促進剤;硫黄、チアントール等の抗脂漏剤;トラネキサム酸、チオタウリン、ヒポタウリン等の抗炎症剤;コラーゲン、ヒアルロン酸等の水溶性高分子;などが挙げられる。
Lower alcohols such as ethanol and isopropanol; vitamin A or derivatives thereof, vitamin B 6 hydrochloride, vitamin B 6 tripalmitate, vitamin B 6 dioctanoate, vitamin B 2 or derivatives thereof, vitamin B 12 , vitamin B 15 or derivatives thereof B vitamins such as α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E such as vitamin E acetate, vitamin D, vitamin H, pantothenic acid, pantethine, pyrroloquinoline quinone, etc.; antibacterial agents (preservatives) such as ethylparaben, butylparaben, and phenoxyethanol; antiphlogistic agents such as glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, and allantoin; retinol, ascorbic acid, tocopherol, farnesyl acetate, etc. wrinkle-improving agents; various extracts (e.g., Phellodendron bark, Japanese coptis, rhododendron, peony, assembly, birch, sage, loquat, carrot, aloe, mallow, iris, grape, coix seed, loofah, lily, saffron, cnidium, ginger, hypericum, ononis, garlic, hot pepper, chimp, angelica root, seaweed, etc.); activators such as royal jelly, photosensitizers and cholesterol derivatives; seborrheic agents; anti-inflammatory agents such as tranexamic acid, thiotaurine and hypotaurine; water-soluble polymers such as collagen and hyaluronic acid;
以下、本発明を実施例により更に詳細に説明するが、本発明は、その要旨を超えない限り、以下の実施例に限定されるものではない。 EXAMPLES Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited to the following examples as long as the gist thereof is not exceeded.
<実施例>マイオネクチンのIL-1α発現量への影響の検討
以下の手順で、マイオネクチンを添加したケラチノサイトにおけるIL-1α発現量を測定した。
12ウェルプレートの各ウェルに基礎培地(HUMedia-KG2培地名、(クラボウ社製))
を0.5mLずつ入れ、そこにヒトケラチノサイト(クラボウ社製、Lot #06445)
の懸濁液0.5mLを播種(6.0×104 cells/ウェル)して1.0mL/ウェルで37℃、5%CO2条件下で48時間培養した。培養後、物理刺激を模するためミクロスパーテル(具体的な手段)でwellの直径に対し横一直線にスクラッチを行い、マイオネクチン含有培地(マイオネクチン濃度100ng/mL、HUMedia-KG2培地名、(
クラボウ社製))0.5mL/ウェルに交換し、37℃、5%CO2条件下で24時間培養した。培養後に細胞をPBSで洗浄した後回収し、QIAcube(QIAGEN社製)を用いてm
RNAを抽出した。Fast SYBR Green Master Mix 5ml(Applied Biosystems)、Superscript VILO cDNA Synthesis kit 250T(Invitrogen)、Hs_IL1A_1_SG QuantiTect Primer Assay (QIAGEN , QT00001127 , Cat.249900)を用いて、RT-qPCRを行い、IL-1α
の発現量を解析した。
<Example> Examination of the effect of myonectin on IL-1α expression level The IL-1α expression level in myonectin-added keratinocytes was measured by the following procedure.
Basal medium (HUMedia-KG2 medium name, (manufactured by Kurabo Industries)) in each well of a 12-well plate
0.5 mL each, human keratinocytes (manufactured by Kurabo Industries, Lot # 06445)
0.5 mL of the suspension was seeded (6.0×10 4 cells/well) and cultured at 1.0 mL/well under conditions of 37° C. and 5% CO 2 for 48 hours. After culturing, in order to imitate physical stimulation, a microspatula (specific means) was used to scratch the diameter of the well in a horizontal straight line, and a myonectin-containing medium (myonectin concentration: 100 ng/mL, HUMedia-KG2 medium name, (
Kurabo)) was changed to 0.5 mL/well, and cultured for 24 hours at 37° C. and 5% CO 2 conditions. After culturing, the cells were washed with PBS, collected, and analyzed using a QIAcube (manufactured by QIAGEN).
RNA was extracted. RT-qPCR was performed using Fast SYBR Green Master Mix 5ml (Applied Biosystems), Superscript VILO cDNA Synthesis kit 250T (Invitrogen), Hs_IL1A_1_SG QuantiTect Primer Assay (QIAGEN, QT00001127, Cat.249900) to detect IL-1α.
was analyzed for the expression level of
図1に、ケラチノサイトにおけるIL-1α遺伝子のmRNA発現量を、物理刺激を与えなかった場合のケラチノサイトにおけるIL-1α遺伝子のmRNA発現量を1とした場合の相対値で示した。
マイオネクチンを添加したケラチノサイトにおいて、IL-1α遺伝子のmRNA発現量が未添加の細胞よりも有意に小さく、マイオネクチンによりIL-1α発現が抑制されることがわかった。
FIG. 1 shows the mRNA expression level of IL-1α gene in keratinocytes as a relative value when the mRNA expression level of IL-1α gene in keratinocytes without physical stimulation is set to 1.
In keratinocytes to which myonectin was added, the mRNA expression level of the IL-1α gene was significantly lower than in cells to which no addition was added, indicating that myonectin suppresses IL-1α expression.
<参考例>各種エキスのマイオネクチン産生促進作用確認
以下の手順で、各種エキスを調製し、被験エキスとした。
マンゴージンジャーエキス:乾燥したショウガ科ウコン属マンゴージンジャーの全草に、10倍量の30%エタノール水溶液を加えて、還流して抽出した液を、凍結乾燥により粉末化した。
ハスの花エキス:乾燥したハス科ハス属ハスの花及び花蕾に、10倍量の30%エタノール水溶液を加えて、還流して抽出した液を、凍結乾燥により粉末化した。
キャッツクローエキス:乾燥したアカネ科カギカズラ属キャッツクローの全草に、10倍量の30%エタノール水溶液を加えて、還流して抽出した液を、凍結乾燥により粉末化した。
インディアンデーツエキス:乾燥したシマメ科ジャケツイバラ亜科タマリンド属タマリンドの果実に、10倍量の30%エタノール水溶液を加えて、還流して抽出した液を、凍結乾燥により粉末化した。
<Reference Example> Confirmation of myonectin production-promoting action of various extracts Various extracts were prepared according to the following procedures and used as test extracts.
Mango ginger extract: Ten times the amount of 30% ethanol aqueous solution was added to dried whole mango ginger of the genus Curcuma belonging to the Zingiberaceae family, and the liquid extracted by refluxing was powdered by freeze-drying.
Lotus flower extract: 10 times the amount of 30% ethanol aqueous solution was added to dried lotus flowers and flower buds of the genus Lotus of the Lotus family, and the liquid extracted by refluxing was powdered by freeze-drying.
Cat's claw extract: A 10-fold volume of 30% aqueous ethanol solution was added to the dried whole plant of the genus Cat's claw of the family Rubiaceae, and the mixture was refluxed and extracted.
Indian date extract: Ten times the amount of 30% aqueous ethanol solution was added to dried fruit of the genus Tamarind, Caesalpinaceae, Caesalpinae, Tamarind, and the extract was extracted by refluxing, and freeze-dried to form a powder.
以下の手順で、被験エキスを添加した筋細胞におけるマイオネクチン遺伝子発現量を測定した。
ヒト骨格筋筋芽細胞Lonza CC-2580(Lonza社製、Lot #29715)を24ウェルプレートに播種(4×104cells/ウェル)し、基礎培地(SkGM-2 BulletKit(Lonza:CC-3245))0.5mL/ウェルで37℃、5%CO2条件下で24時間培養した。培養後、基礎培地を除去してPBSで洗浄し、分化培地(DMEM:F-12(Lonza:12-719F)+2% Horse Serum(Gibco:16050-130)+1% a.a(Gibco:15240062))1.0mL/
ウェルを添加して37℃、5%CO2条件下で72時間培養した。培養後、分化培地を除去して、所定の固形分濃度となるように被験エキスを添加した分化培地を1.0mL/ウェルずつ添加して37℃、5%CO2条件下で72時間培養した。培養後に細胞をPBSで洗浄し、Fast SYBR Green Master Mix(Termo Fisher Scientific社製)、Hs_FAM132B_4_SG QuantiTect Primer Assay (QIAGEN 社製、マイオネクチンFAM132B遺伝子測定用)
、及びHs_TBP_1_SG QuantiTect Primer Assay(QIAGEN社製、内在性コントロール)を用
いて、qRT-PCRを行い、マイオネクチン遺伝子(FAM132B)の発現量を解析
した。
The myonectin gene expression level in muscle cells to which the test extract was added was measured by the following procedure.
Human skeletal muscle myoblast Lonza CC-2580 (manufactured by Lonza, Lot #29715) was seeded in a 24-well plate (4 × 10 4 cells/well), and a basal medium (SkGM-2 Bullet Kit (Lonza: CC-3245) ) at 0.5 mL/well at 37° C. and 5% CO 2 conditions for 24 hours. After culturing, the basal medium was removed, washed with PBS, and differentiated medium (DMEM: F-12 (Lonza: 12-719F) + 2% Horse Serum (Gibco: 16050-130) + 1% aa (Gibco: 15240062)) 1 .0mL/
The wells were added and cultured at 37°C, 5% CO2 for 72 hours. After culturing, the differentiation medium was removed, 1.0 mL/well of the differentiation medium supplemented with the extract to be tested was added to give a predetermined solid content concentration, and the cells were cultured at 37° C. and 5% CO 2 for 72 hours. . After culturing, the cells were washed with PBS, and subjected to Fast SYBR Green Master Mix (manufactured by Termo Fisher Scientific), Hs_FAM132B_4_SG QuantiTect Primer Assay (manufactured by QIAGEN, for myonectin FAM132B gene measurement).
, and Hs_TBP_1_SG QuantiTect Primer Assay (manufactured by QIAGEN, endogenous control), qRT-PCR was performed to analyze the expression level of the myonectin gene (FAM132B).
図2~5に、筋細胞におけるマイオネクチン遺伝子のmRNA発現量を、溶媒対照の筋細胞におけるマイオネクチン遺伝子のmRNA発現量を1とした場合の相対値で示した。 2 to 5 show the mRNA expression level of myonectin gene in muscle cells as a relative value when the mRNA expression level of myonectin gene in solvent control muscle cells is set to 1. FIG.
各エキスを添加した筋細胞において、マイオネクチン遺伝子のmRNA発現量がコントロールに対して増加傾向が認められた。特に、マンゴージンジャーエキスを添加した筋細胞において、マイオネクチン遺伝子のmRNA発現量がコントロールに対して有意に増加した。したがって、これらの植物エキスはマイオネクチン産生促進剤となり得、またそのマイオネクチン産生促進作用によりIL-1α発現抑制用組成物の有効成分となり得ることが理解できる。 In muscle cells to which each extract was added, an increase in the expression level of myonectin gene mRNA was observed relative to the control. In particular, in the muscle cells to which the mango ginger extract was added, the mRNA expression level of the myonectin gene was significantly increased compared to the control. Therefore, it can be understood that these plant extracts can serve as myonectin production promoting agents, and can also serve as active ingredients of compositions for suppressing IL-1α expression due to their myonectin production promoting action.
本発明により、マイオネクチンのIL-1α発現抑制という新たな用途が提供される。また、マイオネクチン産生促進剤をIL-1α発現抑制用組成物の有効成分とする態様も提供される。これらの剤や組成物は飲食品や皮膚外用剤の態様とすることができ、手軽にまた継続的に生活に取り入れることができるため、産業上非常に有用である。 INDUSTRIAL APPLICABILITY The present invention provides a new use of myonectin for suppressing IL-1α expression. Also provided is an embodiment in which the myonectin production promoter is used as an active ingredient of a composition for suppressing IL-1α expression. These agents and compositions can be in the form of foods, beverages, and external preparations for skin, and can be easily and continuously incorporated into daily life, making them very useful industrially.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021187136A JP2023074268A (en) | 2021-11-17 | 2021-11-17 | IL-1α expression inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021187136A JP2023074268A (en) | 2021-11-17 | 2021-11-17 | IL-1α expression inhibitor |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023074268A true JP2023074268A (en) | 2023-05-29 |
Family
ID=86537712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021187136A Pending JP2023074268A (en) | 2021-11-17 | 2021-11-17 | IL-1α expression inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2023074268A (en) |
-
2021
- 2021-11-17 JP JP2021187136A patent/JP2023074268A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6745250B2 (en) | Moringa extract | |
KR101767248B1 (en) | Composition for prevention and treatment of muscular disorder or improvement of muscular functions comprising Mori Cortex Radicis extract, morusin, or kuwanon G | |
JP2012140360A (en) | Antioxidant, cosmetic, food and drink composition and pharmaceutical composition | |
JP2022116116A (en) | Food-and-drink composition | |
JP2010053122A (en) | Lipid synthesis inhibitor | |
JP2009107965A (en) | Ceramide synthesis promoter, and external preparation for skin and food and drink | |
JP5224234B2 (en) | Platelet aggregation inhibitor | |
JP2010132575A (en) | Skin brightener and use thereof | |
EP2990035B1 (en) | 1,5-anhydro-d-glucitol-containing collagen production accelerator | |
JP6718158B2 (en) | Liver function improver | |
JP7130900B2 (en) | Composition | |
JP4084726B2 (en) | Collagen synthesis promoter, fibroblast proliferation promoter, cyclic AMP phosphodiesterase inhibitor, tyrosinase inhibitor, platelet aggregation inhibitor, cosmetics and food and drink. | |
JP2023074268A (en) | IL-1α expression inhibitor | |
JP2010037221A (en) | Adiponectin production enhancer | |
JP4224593B2 (en) | Composition for suppressing fat accumulation comprising wasabi as an active ingredient | |
JP5582593B2 (en) | Platelet aggregation inhibitor | |
JP2023059099A (en) | myonectin production promoter | |
TW201247197A (en) | Whitening agent and melanin production inhibitor | |
JP5507437B2 (en) | Antioxidants, cosmetics, food and beverage compositions and pharmaceutical compositions | |
JP7320270B2 (en) | Liver function improver | |
JP2019073476A (en) | Agent for atp production promotion | |
JP5665117B2 (en) | Antioxidants, cosmetics, food and beverage compositions and pharmaceutical compositions | |
JP5527736B2 (en) | Platelet aggregation inhibitor | |
JP2013082738A (en) | Platelet aggregation inhibitor | |
JP2023064345A (en) | Agent for preventing or improving blotches and screening method therefor |